Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Significant movement in price has been observed in Indo Us Biotech Limited. The Exchange in order to ensure that investors have latest relevant infor...more...
Clarification on Price Movement.more...
The Exchange has sought clarification from Indo Us Bio-Tech Ltd on March 10 2026 with reference to significant movement in price in order to ensure t...more...
Significant movement in price has been observed in Indo Us Biotech Limited. The Exchange in order to ensure that investors have latest relev...more...
The Exchange had sought clarification from Indo Us Biotech Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listi...more...
Indo Us Biotech Limited has informed the Exchange regarding Submit the machine-readable of financial results for the period ended 31-Dec-2025. .more...
Indo Us Biotech Limited has informed the Exchange about Copy of Newspaper Publication relating to the Unaudited Quarterly Standalone Financial Result...more...
The company reported standalone net profit of Rs 3.00 crore for the quarter ended December 31 2025 as compared to Rs 5.05 crore in the same ...more...
Integrated Filing (Financial) for the quarter and nine-months endedon 31st December 2025more...
Indo Us Biotech Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Indo Us Biotech Limited has informed the Exchange regarding Board meeting held on January 21 2026.more...
Financial Resultsmore...
Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation 2015 we wish to inform you that the Board of D...more...
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 inter alia to cons...more...
As of December 2025 70.18% is owned by Indian Promoters and 29.83% by Public. Top five Promoters holding highest number of shares of Indo US Bio-Tech...more...
The Exchange has sought clarification from Indo Us Biotech Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SE...more...
Indo Us Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018more...
Certificate under Reg 74(5) of SEBI DP Reg. for the quarter ended on 31st Dec 2025.more...
Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations ...more...
Indo Us Biotech Limited has informed the Exchange about Action(s) initiated_Receipt of Summons from the Directorate of Enforcement (ED) unde...more...
BOARD MEETINGS Company Name : Beryl Drugs Date : 01-04-2026